Evaluation of a combined triple method to detect causative HPV in oral and oropharyngeal squamous cell carcinomas: P16 Immunohistochemistry, Consensus PCR HPV-DNA, and in Situ Hybridization

Infectious Agents and Cancer

Volumn 7, Issue 1, 2012, Pages

  Pannone, Giuseppe ^a   Rodolico, Vito ^b   Santoro, Angela ^a   Lo Muzio, Lorenzo ^a   Franco, Renato ^c   Botti, Gerardo ^c   Aquino, Gabriella ^c   Pedicillo, Maria ^a   Cagiano, Simona ^a   Campisi, Giuseppina ^b   Rubini, Corrado ^d   Papagerakis, Silvana ^e   De Rosa, Gaetano ^f   Tornesello, Maria Lina ^c   Buonaguro, Franco M ^c   Staibano, Stefania ^f   Bufo, Pantaleo ^a  

^a UNIVERSITY OF FOGGIA   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^f UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

DNA consensus PCR; Epigenetic; Head and neck squamous cell carcinoma; HN SCC; HPV; Human papillomavirus; IHC; Immunohistochemistry; Methylation Specific PCR; OPSCC; OSCC; p16 IHC

Indexed keywords

PARAFFIN; PROTEIN P16; VIRUS DNA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DETERMINATION; DNA METHYLATION; EPIGENETICS; FEMALE; GENE INACTIVATION; GENE LOCUS; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MOUTH CARCINOMA; MOUTH CAVITY; NONHUMAN; OROPHARYNX; OROPHARYNX CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RELIABILITY; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; VIRUS DNA CELL DNA INTERACTION; WART VIRUS;

EID: 84857478688     PISSN: None     EISSN: 17509378     Source Type: Journal    
DOI: 10.1186/1750-9378-7-422376902     Document Type: Article

References (49)

1. Gillison ML, Koch WM, Capone RB: Evidence for a causal association between human papillomavirus and a subset of Head and Neck Cancers. J Natl Cancer Inst 2000, 92:709-720. (Pubitemid 30365531)
2. Lo Muzio L, Campisi G, Giovannelli L, Ammatuna P, Greco I, Staibano S, Pannone G, De Rosa G, Di Liberto C, D' Angelo M: HPV-DNA and survivin expression in epithelial oral carcinogenesis: a relationship? Oral Oncol 2004, 40(7):736-741.
3. Paz IB, Cook N, Odom-Maryon T, et al: Human papillomavirus (HPV) in Head and Neck Cancer: an association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring. Cancer 1997, 79:595-604. (Pubitemid 27051787)
4. Ryerson AB, Peters ES, Coughlin SS, et al: Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998-2003. Cancer 2008, 113:2901-2909.
5. Charfi L, Jouffroy T, de Cremoux P, et al: Two types of squamous cell carcinoma of the palatine tonsil characterized by distinct etiology, molecular features and outcome. Cancer Lett 2008, 260:72-78.
6. Pannone G, Santoro A, Papagerakis S, Lo Muzio L, De Rosa G, Bufo P: The role of human papillomavirus in the pathogenesis of head & neck squamous cell carcinoma: an overview. Infectious Agents and Cancer 2011, 6:4.
7. Syrjänen K, Syrjänen S, Lamberg M, Pyrhönen S, Nuutinen J: Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis. Int J Oral Surg 1983, 12:418-424. (Pubitemid 14141093)
8. Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S: Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003, 88:63-73.
9. Campisi G, Panzarella V, Giuliani M, Lajolo C, Di Fede O, Falaschini S, Di Liberto C, Scully C, Lo Muzio L: Human papillomavirus: its identity and controversial role in oral oncogenesis, premalignant and malignant lesions (review). Int J Oncol 2007, 30(4):813-823.
10. Syrjänen S, Lodi G, von Bültzingslöwen I, Aliko A, Arduino P, Campisi G, Challacombe S, Ficarra G, Flaitz C, Zhou HM, Maeda H, Miller C, Jontell M: Human papillomaviruses in oral carcinoma and oral potentially malignant disorders: a systematic review. Oral Dis 2011, 17(S1):58-72.
11. Termine N, Panzarella V, Falaschini S, Russo A, Matranga D, Lo Muzio L, Campisi G: HPV in oral squamous cell carcinoma vs Head and Neck squamous cell carcinoma biopsies: a meta-analysis (1988-2007). Ann Oncol 2008, 19(10):1681-1690.
12. Cairns P, Polascik TJ, Eby Y, Tokino K, Califano J, Merlo A, Mao L, Herath J, Jenkins R, Westra W, et al: Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nat Genet 1995, 11(2):210-212.
13. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB, Sidransky D: 5'CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1995, 1(7):686-692.
14. Herman JG, Merlo A, Mao L, Lapidus RG, Issa JP, Davidson NE, Sidransky D, Baylin SB: Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 1995, 55(20):4525-4530.
15. Gonzalez-Zulueta M, Bender CM, Yang AS, Nguyen T, Beart RW, Van Tornout JM, Jones PA: Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res 1995, 55(20):4531-4535.
16. Reed AL, Califano J, Cairns P, Westra WH, Jones RM, Koch W, Ahrendt S, Eby Y, Sewell D, Nawroz H, Bartek J, Sidransky D: High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in Head and Neck squamous cell carcinoma. Cancer Res 1996, 56(16):3630-3633. (Pubitemid 26272001)
17. Rischin D, Young R, Fisher R, Le Q, Peters L, Choi J, O'Sullivan B, Giralt J, McArthur G: Prognostic significance of HPV and p16 status in patients with oropharyngeal cancer treated on a large international phase III trial [abstract]. J Clin Oncol 2009, 27(15s):Ab 6004.
18. Reimers N, Kasper HU, Weissenborn SJ, et al: Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer. Int J Cancer 2007, 120:1731-1738. (Pubitemid 46399359)
19. National Comprehensive Cancer Network (NCCCN) Guidelines™ Version 1. 2011-Head and Neck Cancers. [http://www.nccn.org/professionals/physician-gls/ f-guidelines.asp].
20. Umudum H, Rezanko T, Dag F, Dogruluk T: Human papillomavirus genome detection by in situ hybridization in fine-needle aspirates of metastatic lesions from head and neck squamous cell carcinomas. Cancer Cytopathol 2005, 105(3):171-177. (Pubitemid 40868897)
21. El-Mofty SK, Zhang MQ, Davila RM: Histologic identification of human papillomavirus (HPV)-related squamous cell carcinoma in cervical lymph nodes: a reliable predictor of the site of an occult Head and Neck primary carcinoma. Head Neck Pathol 2008, 2(3):163-168.
22. Pannone G, Santoro A, Carinci F, Bufo P, Papagerakis SM, Rubini C, Campisi G, Giovannelli L, Contaldo M, Serpico R, Mazzotta M, Lo Muzio L: Double demonstration of oncogenic high risk human papilloma virus DNA and HPV-E7 protein in oral cancers. Int J Immunopathol Pharmacol 2011, 24(S2):95-101.
23. Scapoli L, Palmieri A, Rubini C, Martinelli M, Spinelli G, Ionna F, Carinci F: Low prevalence of human papillomavirus in squamous-cell carcinoma limited to oral cavity proper. Mod Pathol 2009, 22(3):366-372.
24. Hines LE, Ceron-Cabrera D, Romero K, Anthony M, Woosley RL, Armstrong EP, Malone DC: Evaluation of warfarin drug interaction listings in US product information for warfarin and interacting drugs. Clin Ther 2011, 33(1):36-45.
25. Amortegui AJ, Meyer MP, Elborne VL, Amin RM: p53, retinoblastoma gene product, and cyclin protein expression in human papillomavirus virus DNA-positive cervical intraepithelial neoplasia and invasive cancer. Mod Pathol 1995, 8(9):907-912. (Pubitemid 26025967)
26. Keating JT, Cviko A, Riethdorf S, Riethdorf L, Quade BJ, Sun D, Duensing S, Sheets EE, Munger K, Crum CP: Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia. Am J Surg Pathol 2001, 25(7):884-891. (Pubitemid 32594981)
27. O'Neill CJ, McCluggage WG: p16 expression in the female genital tract and its value in diagnosis. Adv Anat Pathol 2006, 13(1):8-15. (Pubitemid 44357144)
28. Marur S, D'Souza G, Westra WH, Forastiere AA: HPV-associated Head and Neck Cancer: a virus-related cancer epidemic. Lancet Oncol 2010, 11(8):781-789.
29. Fischer CA, Kampmann M, Zlobec I, Green E, Tornillo L, Lugli A, Wolfensberger M, Terracciano LM: p16 expression in oropharyngeal cancer: its impact on staging and prognosis compared with the conventional clinical staging parameters. Ann Oncol 2010, 21(10):1961-1966.
30. Doxtader EE, Katzenstein AL: The relationship between p16 expression and high-risk human papillomavirus infection in squamous cell carcinomas from sites other than - uterine cervix: a study of 137 cases. Hum Pathol 2011, 43(3):327-332.
31. El-Mofty SK, Lu DW: Prevalence of human papillomavirus type 16 DNA in squamous cell carcinoma of the palatine tonsil, and not the oral cavity, in young patients: a distinct clinicopathologic and molecular disease entity. Am J Surg Pathol 2003, 27:1463-1470. (Pubitemid 37315200)
32. Cullen AP, Reid R, Campion M, Lörincz AT: Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J Virol 1991, 65:606-612.
33. Dǔrst St M, Kleinheinz A, Hotz M, Gissmann L: The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumours. J Gen Virol 1985, 66:1515-1522. (Pubitemid 15070392)
34. Snijders PJ, Cromme FV, van den Brule AJ, Schrijnemakers HF, Snow GB, Meijer CJ, Walboomers JM: Prevalence and expression of human papillomavirus in tonsillar carcinomas, indicating a possible viral etiology. Int J Cancer 1992, 51(6):845-850.
35. Mellin H, Dahlgren L, Munck-Wikland E, Lindholm J, Rabbani H, Kalantari M, et al: Human papillomavirus type 16 is episomal and a high viral load may be correlated to better prognosis in tonsillar cancer. Int J Cancer 2002, 102:152-158. (Pubitemid 35168028)
36. Prado JC, Calleja-Macias IE, Bernard HU, Kalantari M, Macay SA, Allan B, Williamson AL, Chung LP, Collins RJ, Zuna RE, Dunn ST, Ortiz-Lopez R, Barrera-Saldaña HA, Cubie HA, Cuschieri K, von Knebel-Doeberitz M, Sanchez GI, Bosch FX, Villa LL: Worldwide genomic diversity of the human papillomaviruses-53, 56, and 66, a group of high-risk HPVs unrelated to HPV16 and HPV-18. Virology 2005, 340(1):95-104. (Pubitemid 41191181)
37. Kim SH, Koo BS, Kang S, Park K, Kim H, Lee KR, Lee MJ, Kim JM, Choi EC, Cho NH: HPV integration begins in the tonsillar crypt and leads to the alteration of p16, EGFR and c-myc during tumor formation. Int J Cancer 2007, 120(7):1418-1425. (Pubitemid 46355375)
38. van Houten VM, Snijders PJ, van den Brekel MW: Biological evidence that human papillomaviruses are etiologically involved in a subgroup of Head and Neck squamous cell carcinomas. Int J Cancer 2001, 93:232-235. (Pubitemid 32574279)
39. Klussmann JP, Weissenborn SJ, Wieland U, Dries V, Kolligs J, Jungehuelsing M, et al: Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas. Cancer 2001, 92(11):2875-2884.
40. Schache AG, Triantafilos Liloglou, Risk Janet M, Anastasia Filia, Jones Terence M, Jon Sheard, Woolgar Julia A, Helliwell Timothy R, Asterios Triantafyllou, Max Robinson, Philip Sloan, Colin Harvey-Woodworth, Daniel Sisson, Shaw Richard J: Evaluation of Human Papilloma Virus Diagnostic Testing in Oropharyngeal Squamous Cell Carcinoma: Sensitivity, Specificity, and Prognostic Discrimination. Clin Cancer Res 2011, 17:6262-6271.
41. Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, et al: American Joint Committee on Cancer New York: Cancer Staging Manual. Springer; 2002.
42. Husnjak K, Grce M, Magdić L, Pavelić K: Comparison of five different polymerase chain reaction methods for detection of human papillomavirus in cervical cell specimens. J Virol Methods 2000, 88(2):125-134.
43. Cooper K, Herrington CS, Stickland JE, Evans MF, McGee JO: Episomal and integrated human papillomavirus in cervical neoplasia shown by non-isotopic in situ hybridization. J Clin Pathol 1991, 44:990-996.
44. Evans MF, Mount SL, Beatty BG, Cooper K: Biotinyltyramide-based in situ hybridization signal patterns distinguish human papillomavirus type and grade of cervical intraepithelial neoplasia. Mod Pathol 2002, 15:1339-1347. (Pubitemid 35463003)
45. Guo M, Gong Y, Deavers M, Silva EG, Jan YJ, Cogdell DE, Luthra R, Lin E, Lai HC, Zhang W, Sneige N: Evaluation of a commercialized in situ hybridization assay for detecting human papillomavirus DNA in tissue specimens from patients with cervical intraepithelial neoplasia and cervical carcinoma. J Clin Microbiol 2008, 46(1):274-280.
46. Hopman AH, Kamps MA, Smedts F, Speel EJ, Herrington CS, Ramaekers FC: HPV in situ hybridization: impact of different protocols on the detection of integrated HPV. Int J Cancer 2005, 115(3):419-428. (Pubitemid 40663746)
47. Hale CA, Fleiss JL: Interval estimation under two study designs for kappa with binary classifications. Biometrics 1993, 49(2):523-534. (Pubitemid 23217987)
48. Nam JM: Interval estimation of the kappa coefficient with binary classification and an equal marginal probability model. Biometrics 2000, 56(2):583-585.
49. Landis JR, Koch GG: The measurement of observer agreement for categorical data. Biometrics 1977, 33(1):159-174. (Pubitemid 8054849)